Skip to content

Author

Ehsanullah Alokozay

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Abstract 5159: Comparative Effectiveness and Safety of Myval versus Evolut Transcatheter Heart Valves in Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Introduction/Background: The Myval balloon-expandable transcatheter heart valve (THV) has emerged as an alternative to established platforms; however, comparative evidence with the Evolut self-expanding THV remains limited, particularly regarding procedural performance and conduction outcomes. Research Question...

Fatima Sohail, M. Asim, A. Mohamed et al. · 0 citations
Review Nov 2026

Abstract 4635: Efficacy and Safety of Baxdrostat for Hypertension: A Systematic Review and Meta-Analysis of Three Phase 2/3 Randomized Controlled Trials

Introduction: Baxdrostat is a selective aldosterone synthase (CYP11B2) inhibitor evaluated in three phase 2/3 randomized controlled trials (RCTs) for treatment-resistant and uncontrolled hypertension. However, no dedicated quantitative synthesis has characterized its blood pressure-lowering efficacy, dose-response r...

Rahul Falodia, Ehsanullah Alokozay, Saeedullah Zadran et al. · 0 citations
Nov 2026

Abstract 11617: Cardiovascular Outcomes in Patients with Fatty Change of Liver Treated with Combined GLP-1 RA and SGLT2 Inhibitor Therapy versus GLP-1 RA Alone: A Propensity Score Matched TriNetX Analysis

Background: Fatty change of the liver is strongly associated with cardiovascular risk due to insulin resistance, dyslipidemia, and systemic inflammation. GLP-1 receptor agonists (GLP-1 RAs) and SGLT2 inhibitors (SGLT2is) each provide independent cardiovascular benefits. This study assesses whether combination therap...

M. Azhar, Aneesa Altaf, Ehsanullah Alokozay et al. · 0 citations
Open access Aug 2026

Temporal Trends in Colorectal Cancer Associated With Type 2 Diabetes Mellitus in U.S. Adults, 1999–2023: A CDC Wonder Database Analysis—A Population‐Based Cross‐Sectional Study

Trends in CRC‐related deaths among individuals with coexisting T2DM in the United States from 1999 to 2023 are analyzed, as well as disparities among different demographic and geographic groups are explored.

Waleed Tariq, Neha Waseem, Mehreen Maka et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.